Oura, the Finnish company known for its smart rings and health-tracking technology, is set to acquire AI-native primary care startup Counsel Health for $625 million in a combination of cash and stock. The proposed acquisition marks a major strategic shift for Oura as it looks to expand from a wearable hardware business into an integrated health technology and services platform.
The deal comes weeks after Oura postponed its planned initial public offering (IPO), which had reportedly targeted a valuation of up to $2.2 billion. The company cited uncertainty in the IPO market as the reason for delaying the listing.
Through the acquisition, Oura aims to combine its biometric monitoring capabilities with Counsel Health’s AI-powered primary care technology, potentially enabling users to move beyond tracking health metrics towards receiving personalised health guidance and access to medical care.
Counsel Health Brings AI-Powered Primary Care Capabilities
Counsel Health develops AI-powered primary care technology designed to help patients navigate healthcare needs through digital interactions. Its platform uses machine learning models to assess symptoms, recommend appropriate next steps and connect users with human physicians when required.
The technology is designed to analyse patient information and provide personalised health guidance, extending digital healthcare services beyond conventional fitness and wellness tracking.
For Oura, the acquisition could create a pathway to translate biometric information collected through its smart rings into more actionable health insights. The company’s devices track indicators such as sleep, activity and recovery, giving users a picture of their overall health patterns.
Integrating Counsel Health’s capabilities could allow Oura to connect these measurements with AI-supported health guidance and physician-led care.
From Wearable Hardware to an Integrated Health Platform
Oura has established its position in the wearable technology market through its smart rings, which monitor health-related metrics and provide insights into sleep, recovery and activity.
The Counsel Health acquisition represents an attempt to expand this offering into healthcare services. Rather than limiting its role to collecting and presenting health data, Oura could potentially provide users with a more comprehensive experience combining continuous monitoring, personalised insights and access to primary care.
The strategy also places Oura in a broader competitive landscape that includes technology companies expanding their healthcare offerings. Apple has continued to develop health-monitoring features through the Apple Watch, while Amazon has expanded its presence in pharmacy and telehealth services.
Oura’s proposed approach centres on connecting passive biometric monitoring with AI-driven healthcare support.
Acquisition Follows Postponement of Planned IPO
The timing of the transaction is notable. Oura recently postponed its planned IPO, which was reportedly expected to value the company at up to $2.2 billion, citing uncertainty in public markets.
The $625 million acquisition represents a substantial strategic commitment as the company evaluates its next phase of growth.
Oura has raised more than $300 million from investors, including Dexcom, Eisai and other prominent backers, according to the information provided. The acquisition signals a shift in the company’s growth strategy, with healthcare services becoming a potential addition to its established wearable technology business.
AI Healthcare Market Sees Growing Consolidation
The proposed deal comes amid increasing investment and competition in healthcare artificial intelligence. Startups are developing AI applications across primary care, diagnostics, patient management and drug discovery, while established technology and healthcare companies are exploring ways to integrate AI into their services.
The acquisition also reflects a broader trend of established technology businesses acquiring specialised AI capabilities rather than developing every component internally.
Other healthcare technology companies, including Even Healthcare, have also attracted investor attention. The sector’s growth is creating opportunities for companies that can combine technology, patient engagement and healthcare delivery.
However, integrating AI into primary care involves more than developing sophisticated models. Companies must address clinical oversight, patient safety, data privacy and regulatory compliance.
Questions Around Integration, Privacy and Monetisation
While the acquisition could expand Oura’s service offering, its commercial success will depend on how effectively the two businesses integrate their technologies.
Several details remain unclear, including when Counsel Health’s services will become available to Oura users, whether the offering will be included in existing subscriptions or introduced as a premium service, and which markets will receive access.
The integration also raises questions about how biometric and medical information will be collected, processed and shared. As wearable devices increasingly become part of digital healthcare systems, protecting sensitive health information and maintaining user trust will be critical.
Oura will also need to determine how to build a sustainable revenue model around primary care services while managing the operational and regulatory complexities associated with healthcare delivery.
A New Direction for the Wearables Industry
The acquisition signals a possible evolution in the wearable technology market, where hardware manufacturers are increasingly looking towards software, subscriptions and services to deepen customer relationships and create recurring revenue opportunities.
For Oura, bringing Counsel Health into its operations could help transform its smart ring ecosystem into a more comprehensive health platform.
The outcome will depend on the company’s ability to integrate AI-powered healthcare with its existing products while maintaining clinical standards, data privacy and user confidence. If successful, the strategy could offer a model for how wearable technology companies participate more directly in healthcare delivery.
By : Vanshika Tayal
